1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Instruments & Supplies
Kestra Medical Technologies, Ltd.

Kestra Medical Technologies, Ltd.

KMTS
Kestra Medical Technologies, Ltd.US flagNASDAQ Global Select
23.24
USD
-1.18
- -
1.36BMarket Cap

Total Valuation

Kestra Medical Technologies, Ltd. carries a market capitalization of 1.36B, placing it among publicly traded companies globally. Its enterprise value stands at 974.03M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap1.36B
Enterprise Value974.03M

Share Statistics

Kestra Medical Technologies, Ltd. currently has 58.38M shares outstanding.

Shares Outstanding58.38M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 11.81, and the price-to-book ratio stands at -1.89.

PE RatioN/A
PS Ratio11.81
PB Ratio-1.89
P/TBV Ratio4.33
P/FCF Ratio-24.28
P/OCF Ratio-13.75

Enterprise Valuation

EV / Sales10.24
EV / EBITDAN/A
EV / EBITN/A
EV / FCFN/A

Financial Position

Kestra Medical Technologies, Ltd. maintains a current ratio of 4.41, meaning it holds 4.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 18.02, indicating elevated leverage, while an interest coverage ratio of -16.70 demonstrates limited ability to service its debt obligations.

Current Ratio4.41
Quick Ratio4.19
Debt / Equity18.02
Debt / EBITDA-0.37
Interest Coverage-16.70

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)-40.24
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover6.97

Taxes

Income Tax294,000.00
Effective Tax RateN/A

Stock Price Statistics

Kestra Medical Technologies, Ltd.'s stock has gained approximately 39.74744% over the past 52 weeks. The 50-day moving average sits at 22.18, while the 200-day moving average is 23.59.

Beta (5Y)N/A
52-Week Price Change39.74744%
50-Day Moving Average22.18
200-Day Moving Average23.59
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Kestra Medical Technologies, Ltd. generated 95.13M in revenue and converted that into -131.61M in net income, yielding earnings per share of -2.43. EBITDA reached -126.03M, while operating income came in at -134.74M.

Revenue95.13M
Gross Profit48.86M
Operating Income-134.74M
Pretax Income-131.32M
Net Income-131.61M
EBITDA-126.03M
EBIT-134.74M
Earnings Per Share (EPS)-2.43

Balance Sheet

Kestra Medical Technologies, Ltd. holds 196.43M in cash and equivalents against 46.79M in total debt, resulting in a net debt position of -57.06M. Total book value stands at -593.48M, with working capital of 171.99M providing operational flexibility.

Cash & Cash Equivalents196.43M
Total Debt46.79M
Net Debt-57.06M
Equity (Book Value)-593.48M
Book Value Per Share-10.94
Working Capital171.99M

Cash Flow

Kestra Medical Technologies, Ltd. produced -81.70M in operating cash flow over the past twelve months. After subtracting -35.42M in capital expenditures, free cash flow totaled -117.12M - equivalent to -2.16 per share.

Operating Cash Flow-81.70M
Capital Expenditures-35.42M
Free Cash Flow-117.12M
FCF Per Share-2.16

Margins

Kestra Medical Technologies, Ltd. operates with a gross margin of 51.37, reflecting its pricing power and cost economics. The operating margin of -141.65 and net profit margin of -138.36 provide insight into operational efficiency.

Gross Margin51.37
Operating Margin-141.65
Pretax Margin-138.05
Profit Margin-138.36
EBITDA Margin-132.49

Dividends & Yields

The company's payout ratio of -0.25 indicates the proportion of earnings distributed to shareholders.

Dividend Per Share0.01
Dividend YieldN/A
Payout Ratio-0.25
Shareholder Yield-13.09
FCF Yield-4.12

Scores

Kestra Medical Technologies, Ltd. posts an Altman Z-Score of 3.88, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score3.88